Aurinia Pharmaceuticals also known as AUPH stock at https://www.webull.com/quote/nasdaq-auph,went through a quarterly loss of $0.15 per share compared. It is being compared with the loss of $0.16 per share that the pharma company experienced a year ago. However, these were the figures only of non-recurring items. Non-recurring items are referred to as those entries that take place on the company’s financial statements but are unlikely to take place again.
Aurinia